ArticleCardiovascular diabetology2024
The SGLT2 inhibitor Empagliflozin promotes post-stroke functional recovery in diabetic mice.
Ellen Vercalsteren et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this papercites it